Skip to content

Etiology of allergic contact chielitis and establishment of noninvasive detection method for efficacy evaluation

Etiology of allergic contact chielitis and establishment of noninvasive detection method for efficacy evaluation

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037501
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-10-31
Completion date
Unknown
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic contact chielitis

Interventions

Case series:patch test

Sponsors

Shanghai Skin Disease Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Male or female 18-65 years old; (2) Subjects voluntarily complete the informed consent; (3) Volunteer to participate in this study and comply with the requirements of the test, and respond to any discomfort in a timely manner; (4) The subject is clinically assessed or pathologically diagnosed with contact labitis, with or without peroral dermatitis and/or keratitis; (5) There is no serious damage to the subject's lips or test site; (6) The subject shall ensure that no skin ripping, cupping, acupuncture or other treatments are performed on the test site during the test; (7) The subject is able to accept the patch test and willing to undergo the instrument test; (8) No pregnancy or breast-feeding plan was made throughout the study period, and pregnancy was avoided during the study period; (9) Subjects who are using hormone replacement therapy or hormone birth control shall be able to ensure that they maintain their original use habits during the trial period, and subjects who are not using these hormones shall ensure that they do not use these hormones during the trial period; (10) Subjects who are taking nutritional supplements should maintain their original eating habits during the study period, and explain to the Research Center; (11) There was no oral corticosteroid therapy for nearly a month; (12) The subjects can receive the treatment plan and make regular follow-up visits as required by the project.

Exclusion criteria

Exclusion criteria: (1) Lactating or pregnant women; (2) Subjects frequently or recently used medications that may interfere with the trial (e.g., oral steroids, anti-inflammatory drugs, montelukast, inhaled for more than 3 months or insulin); (3) Subjects with chronic diseases (such as insulin-dependent diabetes mellitus, lupus, rheumatoid arthritis, or other immune/autoimmune diseases) that may affect the study; (4) the subject has a tumor, has been or is currently receiving treatment for tumor, or is currently taking any cancer prevention medication; (5) Those who are exposed to the sun regularly or outdoor workers; (6) Having a cold, fever or other serious illness during the test; (7) Have had facial surgery or cosmetic treatment within 6 months; (8) A history of hyaluronic acid, botox and other injections in the test site within 4 weeks; (9) Other clinical or cosmetic tests shall be conducted in the test area 7 days prior to the start of the test; (10) Highly sensitive to physical conditions.

Design outcomes

Primary

MeasureTime frame
positive rate;

Countries

China

Contacts

Public ContactYiyi Zhang

Shanghai Skin Disease Hospital

zhangyiyi009@163.com+86 18017336720

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026